Article Text

Chronic hepatitis B in hepatocarcinogenesis


Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world, and has a wide geographical variation. Eighty per cent of HCC is attributed to hepatitis B virus (HBV). The predominant carcinogenic mechanism of HBV associated HCC is through the process of liver cirrhosis, but direct oncogenic effects of HBV may also contribute. Prevention of HBV infections as well as effective treatment of chronic hepatitis B is still needed for the global control of HBV associated HCC. Continued investigation of the mechanisms of hepatocarcinogenesis will refine our current understanding of the molecular and cellular basis for neoplastic transformation in the liver.

  • HCC, hepatocellular carcinoma
  • HBV, hepatitis B virus
  • CREB, cAMP response element binding protein
  • NF-κB, nuclear factor κ B
  • TNF, tumour necrosis factor
  • CDK, cyclin dependent kinase
  • VEGF, vascular endothelial growth factor
  • MMP, metalloproteinase
  • IGF, insulin growth factor
  • hepatocellular carcinoma
  • hepatitis b virus
  • hepatitis B x protein (HBx)
  • transactivation

Statistics from


  • Funding: none.

  • Conflicts of interest: none declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.